EA200300480A1 - APPLICATION OF ANTI-PROGESTINES FOR PREVENTION AND TREATMENT OF HORMONIZED DISEASES - Google Patents
APPLICATION OF ANTI-PROGESTINES FOR PREVENTION AND TREATMENT OF HORMONIZED DISEASESInfo
- Publication number
- EA200300480A1 EA200300480A1 EA200300480A EA200300480A EA200300480A1 EA 200300480 A1 EA200300480 A1 EA 200300480A1 EA 200300480 A EA200300480 A EA 200300480A EA 200300480 A EA200300480 A EA 200300480A EA 200300480 A1 EA200300480 A1 EA 200300480A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- application
- prevention
- treatment
- hormonized
- progestines
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
В заявке описаны способы и применения антипрогестинов, в частности антипрогестина 11β-(4-ацетилфенил)-17β-гидрокси-17α-(1,1,2,2,2-пентафторэтил)эстра-4,9-диен-3-она или его фармацевтически приемлемого производного или аналога, для предупреждения или лечения гормонозависимого заболевания, в частности рака молочной железы у млекопитающего. Кроме того, в заявке описаны фармацевтические композиции, содержащие указанный антипрогестин.Международная заявка была опубликована вместе с отчетом о международном поиске.The application describes methods and uses of antiprogestins, in particular antiprogestin 11β- (4-acetylphenyl) -17β-hydroxy-17α- (1,1,2,2,2-pentafluoroethyl) estra-4,9-dien-3-one or its pharmaceutically acceptable derivative or analogue, for the prevention or treatment of a hormone-dependent disease, in particular breast cancer in a mammal. In addition, the application describes pharmaceutical compositions containing the specified antiprogestin. The international application was published along with an international search report.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24099800P | 2000-10-18 | 2000-10-18 | |
| EP00250341 | 2000-10-18 | ||
| PCT/EP2001/012005 WO2002032430A1 (en) | 2000-10-18 | 2001-10-17 | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200300480A1 true EA200300480A1 (en) | 2003-10-30 |
| EA007529B1 EA007529B1 (en) | 2006-10-27 |
Family
ID=34072454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200300480A EA007529B1 (en) | 2000-10-18 | 2001-10-17 | Use of antiprogestines for prophylaxis and treatment of hormone-dependent diseases |
Country Status (8)
| Country | Link |
|---|---|
| AR (1) | AR032371A1 (en) |
| EA (1) | EA007529B1 (en) |
| EC (1) | ECSP034605A (en) |
| PE (1) | PE20020520A1 (en) |
| RS (1) | RS50389B (en) |
| UA (1) | UA75615C2 (en) |
| UY (1) | UY26965A1 (en) |
| ZA (1) | ZA200303793B (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19706061A1 (en) * | 1997-02-07 | 1998-08-13 | Schering Ag | Anti-gestagen effective steroids with fluorinated 17alpha alkyl chain |
-
2001
- 2001-10-12 UY UY26965A patent/UY26965A1/en not_active Application Discontinuation
- 2001-10-16 PE PE2001001025A patent/PE20020520A1/en not_active Application Discontinuation
- 2001-10-17 RS YUP-301/03A patent/RS50389B/en unknown
- 2001-10-17 AR ARP010104867A patent/AR032371A1/en unknown
- 2001-10-17 EA EA200300480A patent/EA007529B1/en not_active IP Right Cessation
- 2001-10-17 UA UA2003054404A patent/UA75615C2/en unknown
-
2003
- 2003-05-14 EC ECSP034605 patent/ECSP034605A/en unknown
- 2003-05-15 ZA ZA200303793A patent/ZA200303793B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY26965A1 (en) | 2002-06-20 |
| ECSP034605A (en) | 2003-06-25 |
| AR032371A1 (en) | 2003-11-05 |
| UA75615C2 (en) | 2006-05-15 |
| EA007529B1 (en) | 2006-10-27 |
| ZA200303793B (en) | 2004-08-16 |
| RS50389B (en) | 2009-12-31 |
| YU30103A (en) | 2006-08-17 |
| PE20020520A1 (en) | 2002-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1104981T1 (en) | USE OF ANTI-PROGESTONES FOR THE PREVENTION AND TREATMENT OF HORMONE DEPENDENT DISEASES | |
| ATE215081T1 (en) | GONADOTROPIN RELEASING HORMONE ANTAGONISTS | |
| DK0402950T3 (en) | Treatment of postmenopausal disadvantages | |
| UA37259C2 (en) | Active substance for pharmaceutical compositions intended for treatment of dysfunctional metrorrhagia | |
| NO20056153L (en) | Preparation comprising antiprogestins and pure antiostrogens for prophylaxis and treatment of hormone-dependent diseases | |
| EA200300479A1 (en) | APPLICATION OF ANTIPROGESTINS FOR INDUCTION OF CELL APOPTOSIS | |
| EA200300480A1 (en) | APPLICATION OF ANTI-PROGESTINES FOR PREVENTION AND TREATMENT OF HORMONIZED DISEASES | |
| YU29903A (en) | Use of antiprogestins for the induction of apoptosis in a cell | |
| TW200733955A (en) | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases | |
| BR9906862A (en) | Use of an effective amount of a hormone replacement agent for the treatment of human menopause and endometriosis | |
| JP2004511523A5 (en) | ||
| UY27301A1 (en) | USE AND COMPOSITIONS OF ANTIPROGESTINES FOR THE TREATMENT OF PROSTATE DISEASES | |
| RU2002130065A (en) | COMPOSITION HAVING CONTRACEPTIVE ACTIVITY |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY RU |